Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Current Deferred Revenue (2020 - 2025)

Definitive Healthcare (DH) has disclosed Current Deferred Revenue for 5 consecutive years, with $93.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Current Deferred Revenue fell 4.14% year-over-year to $93.3 million, compared with a TTM value of $93.3 million through Dec 2024, down 4.14%, and an annual FY2024 reading of $93.3 million, down 4.14% over the prior year.
  • Current Deferred Revenue was $93.3 million for Q4 2024 at Definitive Healthcare, up from $86.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $105.4 million in Q1 2023 and bottomed at $3.4 million in Q1 2022.
  • Average Current Deferred Revenue over 5 years is $80.6 million, with a median of $88.7 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue soared 2998.88% in 2023, then decreased 4.14% in 2024.
  • Year by year, Current Deferred Revenue stood at $61.2 million in 2020, then skyrocketed by 37.29% to $84.0 million in 2021, then grew by 18.65% to $99.7 million in 2022, then decreased by 2.32% to $97.4 million in 2023, then fell by 4.14% to $93.3 million in 2024.
  • Business Quant data shows Current Deferred Revenue for DH at $93.3 million in Q4 2024, $86.2 million in Q3 2024, and $97.4 million in Q4 2023.